Qi Cheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Qi Cheng has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
Wanjie Huang
Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, China
5 shared publicationsYunxiao Shang
Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, China
5 shared publicationsFei Wang
Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, P.R. China
3 shared publicationsHan Zhang
Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China
3 shared publicationsJingjing Yang
Diagnosis and Treatment Center for Children, The Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, Jilin, China
3 shared publicationsNing Chen
Department of Pediatrics, Shengjing Hospital of China Medical University
3 shared publications
Latest Publications
- Open Access
- 15 September 2026
- Published by Spandidos Publications in International Journal of Molecular Medicine
- Vol. 58 (5) , 1-29
Monocytes in pneumonia: Functional plasticity and innate memory (Review)
Pneumonia remains one of the most prevalent and deadly respiratory diseases worldwide, imposing substantial clinical and socioeconomic burdens. Monocytes (Mos) and their progeny are key components of the innate immune system and perform highly context‑dependent roles. The present review summarizes recent advances in understanding Mo biology in pneumonia and discusses current concepts of their functional plasticity. The review first summarizes the developmental origins, phenotypic heterogeneity and functions of circulating Mo subsets, followed by an overview of their recruitment, activation and differentiation in the steady‑state and infected lung. Next, the dual, and at times opposing, roles of Mos and their progeny in pneumonia are examined, including contributions to pathogen clearance and microbial immune evasion, the initiation and resolution of inflammation, and tissue repair vs. fibrotic remodeling. Finally, the review highlights emerging evidence showing that pneumonia can induce durable innate immune memory in Mos, their progenitors and the alveolar macrophage compartment. This reprogramming may reshape subsequent pulmonary and systemic immune responses, with important implications for susceptibility to reinfection, chronic lung dysfunction and host resilience. A deeper understanding of Mo plasticity and innate memory may open new avenues for biomarker discovery and host‑directed therapeutic strategies for pneumonia.
- 15 September 2026
- Published by Spandidos Publications in International Journal of Molecular Medicine
- Vol. 58 (5) , 1-29
Open AccessMonocytes in pneumonia: Functional plasticity and innate memory (Review)
Pneumonia remains one of the most prevalent and deadly respiratory diseases worldwide, imposing substantial clinical and socioeconomic burdens. Monocytes (Mos) and their progeny are key components of the innate immune system and perform highly context‑dependent roles. The present review summarizes recent advances in understanding Mo biology in pneumonia and discusses current concepts of their functional plasticity. The review first summarizes the developmental origins, phenotypic heterogeneity and functions of circulating Mo subsets, followed by an overview of their recruitment, activation and differentiation in the steady‑state and infected lung. Next, the dual, and at times opposing, roles of Mos and their progeny in pneumonia are examined, including contributions to pathogen clearance and microbial immune evasion, the initiation and resolution of inflammation, and tissue repair vs. fibrotic remodeling. Finally, the review highlights emerging evidence showing that pneumonia can induce durable innate immune memory in Mos, their progenitors and the alveolar macrophage compartment. This reprogramming may reshape subsequent pulmonary and systemic immune responses, with important implications for susceptibility to reinfection, chronic lung dysfunction and host resilience. A deeper understanding of Mo plasticity and innate memory may open new avenues for biomarker discovery and host‑directed therapeutic strategies for pneumonia.
- Open Access
- 30 June 2026
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 24 (1)
Neutrophil membrane-mediated biomimetic nanoparticle for co-delivery of icariin and siORMDL3 attenuates asthma exacerbated by respiratory syncytial virus
Asthma is a chronic inflammatory disorder, and respiratory syncytial virus (RSV) is a major trigger of asthma exacerbation. This study aimed to improve therapeutic efficacy against RSV-exacerbated asthma using neutrophil membrane (NM)-coated nanoparticles (NPs) for co-delivery of orosomucoid-like 3 (ORMDL3)-targeting small interfering RNA (siRNA) and icariin. A biomimetic dual-drug delivery system (ORMDL3-targeting siRNA [siORMDL3]/Icariin NPs@NM) was developed by coating NM onto poly(lactic-co-glycolic acid) NPs co-loaded with icariin and siORMDL3. The physicochemical properties, biosafety, cellular uptake, biodistribution behavior, and RNA interference efficiency of the NPs were evaluated. Their therapeutic efficacy was further assessed in vitro and in vivo. The siORMDL3/Icariin NPs@NM exhibited a core-shell structure with NM camouflage, an average diameter of 141.1 nm, and a negatively charged surface. The NPs demonstrated enhanced lung-targeting delivery efficiency with no apparent adverse effects. In vitro, siORMDL3/Icariin NPs@NM significantly improved the viability of BEAS-2B cells treated with interleukin-4 and RSV, while markedly reducing inflammatory cytokine production and oxidative stress markers. In vivo, the siORMDL3/Icariin NPs@NM effectively alleviated airway resistance and improved the inflammatory microenvironment in mice with RSV-exacerbated asthma, with no observable toxicity in major organs. siORMDL3/Icariin NPs@NM demonstrated potent anti-inflammatory and antioxidative effects and may serve as an effective dual-drug delivery platform for the treatment of RSV-exacerbated asthma through combination therapy.
- 30 June 2026
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 24 (1)
Open AccessNeutrophil membrane-mediated biomimetic nanoparticle for co-delivery of icariin and siORMDL3 attenuates asthma exacerbated by respiratory syncytial virus
Asthma is a chronic inflammatory disorder, and respiratory syncytial virus (RSV) is a major trigger of asthma exacerbation. This study aimed to improve therapeutic efficacy against RSV-exacerbated asthma using neutrophil membrane (NM)-coated nanoparticles (NPs) for co-delivery of orosomucoid-like 3 (ORMDL3)-targeting small interfering RNA (siRNA) and icariin. A biomimetic dual-drug delivery system (ORMDL3-targeting siRNA [siORMDL3]/Icariin NPs@NM) was developed by coating NM onto poly(lactic-co-glycolic acid) NPs co-loaded with icariin and siORMDL3. The physicochemical properties, biosafety, cellular uptake, biodistribution behavior, and RNA interference efficiency of the NPs were evaluated. Their therapeutic efficacy was further assessed in vitro and in vivo. The siORMDL3/Icariin NPs@NM exhibited a core-shell structure with NM camouflage, an average diameter of 141.1 nm, and a negatively charged surface. The NPs demonstrated enhanced lung-targeting delivery efficiency with no apparent adverse effects. In vitro, siORMDL3/Icariin NPs@NM significantly improved the viability of BEAS-2B cells treated with interleukin-4 and RSV, while markedly reducing inflammatory cytokine production and oxidative stress markers. In vivo, the siORMDL3/Icariin NPs@NM effectively alleviated airway resistance and improved the inflammatory microenvironment in mice with RSV-exacerbated asthma, with no observable toxicity in major organs. siORMDL3/Icariin NPs@NM demonstrated potent anti-inflammatory and antioxidative effects and may serve as an effective dual-drug delivery platform for the treatment of RSV-exacerbated asthma through combination therapy.
- Open Access
- 19 May 2026
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 13, 1842895
The efficacy of vitamin D supplementation in the management of childhood asthma: a systematic review and meta-analysis
Background: Childhood asthma is a major public health concern. Current evidence regarding vitamin D supplementation in childhood asthma remains inconsistent, particularly with respect to pulmonary function. This study comprehensively evaluates the role of vitamin D supplementation in childhood asthma, with a particular focus on lung function. Method: PubMed, EMBASE, Web of Science, and the Cochrane Library were searched through October 31, 2025 for RCTs. Data were extracted and analyzed using FEV1 (%) as the primary outcome measure, and FVC (%), FEV1/FVC, PEF, FeNO, cACT, and IgE as secondary outcome measures. Results: Twelve RCTs ( n = 1239) were included. We did not find evidence that vitamin D supplementation improves lung function [FEV1 (%): SMD: 0.39, 95% CI: –0.13 to 0.92; FVC (%): SMD: 0.13, 95% CI: –0.73 to 0.98; FEV1/FVC: MD: 0.56, 95% CI: –7.24 to 8.35; PEF: MD: -3.69, 95% CI: –9.71 to 2.34] or cACT scores (MD: 0.16, 95% CI: –0.55 to 0.88), nor does it reduce FeNO or IgE levels (SMD: –0.14, 95% CI: –0.61 to 0.33) in children with asthma. Conclusion: Vitamin D supplementation showed no overall benefit for lung function, IgE levels, FeNO, or cACT scores in children with asthma. Systematic review registration: https://www.crd.york.ac.uk/prospero/ , identifier CRD420251270660.
- 19 May 2026
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 13, 1842895
Open AccessThe efficacy of vitamin D supplementation in the management of childhood asthma: a systematic review and meta-analysis
Background: Childhood asthma is a major public health concern. Current evidence regarding vitamin D supplementation in childhood asthma remains inconsistent, particularly with respect to pulmonary function. This study comprehensively evaluates the role of vitamin D supplementation in childhood asthma, with a particular focus on lung function. Method: PubMed, EMBASE, Web of Science, and the Cochrane Library were searched through October 31, 2025 for RCTs. Data were extracted and analyzed using FEV1 (%) as the primary outcome measure, and FVC (%), FEV1/FVC, PEF, FeNO, cACT, and IgE as secondary outcome measures. Results: Twelve RCTs ( n = 1239) were included. We did not find evidence that vitamin D supplementation improves lung function [FEV1 (%): SMD: 0.39, 95% CI: –0.13 to 0.92; FVC (%): SMD: 0.13, 95% CI: –0.73 to 0.98; FEV1/FVC: MD: 0.56, 95% CI: –7.24 to 8.35; PEF: MD: -3.69, 95% CI: –9.71 to 2.34] or cACT scores (MD: 0.16, 95% CI: –0.55 to 0.88), nor does it reduce FeNO or IgE levels (SMD: –0.14, 95% CI: –0.61 to 0.33) in children with asthma. Conclusion: Vitamin D supplementation showed no overall benefit for lung function, IgE levels, FeNO, or cACT scores in children with asthma. Systematic review registration: https://www.crd.york.ac.uk/prospero/ , identifier CRD420251270660.
- Open Access
- 7 February 2026
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 26 (1)
Age–sex differences in the global burden of asthma and risk factors, 1990–2021: results from the global burden of disease study 2021
Asthma, a prevalent chronic respiratory disease, significantly contributes to global morbidity and mortality. This study aimed to assess the disease burden
- 7 February 2026
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 26 (1)
Open AccessAge–sex differences in the global burden of asthma and risk factors, 1990–2021: results from the global burden of disease study 2021
Asthma, a prevalent chronic respiratory disease, significantly contributes to global morbidity and mortality. This study aimed to assess the disease burden
- Top Cited PapersOpen Access
- 5 January 2026
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 15, 1706340
Immune activation and mucin dysregulation in pediatric refractory Mycoplasma pneumoniae pneumonia with mucus plugs
Objective: Children with refractory Mycoplasma pneumoniae pneumonia (RMPP) experience a prolonged disease course and frequent complications, posing a serious threat to pediatric health. Bronchial mucus plugs appear to play a key role; however, their risk factors and underlying mechanisms remain incompletely defined. We sought to characterize clinical, serologic, and bronchoalveolar lavage fluid (BALF) features associated with mucus plugs in RMPP, assess serum–BALF correlations, and identify independent determinants. Methods: From January 2022 to December 2023, children meeting the criteria for RMPP and requiring bronchoscopy were enrolled, and BALF samples were collected for analysis. Patients were stratified according to the presence or absence of mucus plugs. Clinical features, serologic parameters, BALF cytokine profiles, macrolide-resistance mutations, and epithelial and mucin biomarkers were compared between groups. Correlations between systemic inflammatory markers and BALF markers were analyzed, followed by enrichment analyses of differentially expressed BALF markers. Finally, factors independently associated with mucus plug formation were identified. Results: Eighty-eight children with RMPP were enrolled, including 37 with mucus plugs and 51 without. The mucus plug group required more frequent bronchoscopy and exhibited lower lymphocyte, monocyte, platelet, total protein, albumin, sodium, and potassium levels. Conversely, C-reactive protein (CRP), procalcitonin (PCT), creatine kinase (CK), lactate dehydrogenase (LDH), and serum ferritin levels were markedly elevated. BALF analysis revealed significantly higher levels of interleukin (IL)-2, IL-4, IL-6, IL-12p70, IL-17, interferon-γ (IFN-γ), tumor necrosis factor-α (TNF-α), Krebs von den Lungen-6 (KL-6), surfactant protein A (SP-A), and MUC5B in the mucus plug group. Rates of macrolide-resistance mutations were comparable between groups. Serum LDH, CRP, and CK levels correlated positively with BALF pro-inflammatory cytokines (IL-6, IFN-γ, and TNF-α), whereas albumin and sodium levels showed inverse correlations with these cytokines and with epithelial injury markers (KL-6 and SP-A). Enrichment analyses indicated that differentially expressed cytokines and mucins were primarily involved in inflammation-related pathways and immune effector processes. In multivariable analysis, only serum total protein remained independently associated with mucus plug formation. Conclusions: Children with RMPP and mucus plugs exhibited higher BALF cytokine levels, elevated epithelial injury markers (KL-6 and SP-A), and relatively increased MUC5B expression. Lower serum total protein was independently associated with mucus plug formation. These findings refine the pathophysiological understanding of RMPP with mucus plugs and may inform targeted anti-inflammatory and mucus-modulating therapeutic strategies.
- 5 January 2026
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 15, 1706340
Top Cited PapersOpen AccessImmune activation and mucin dysregulation in pediatric refractory Mycoplasma pneumoniae pneumonia with mucus plugs
Objective: Children with refractory Mycoplasma pneumoniae pneumonia (RMPP) experience a prolonged disease course and frequent complications, posing a serious threat to pediatric health. Bronchial mucus plugs appear to play a key role; however, their risk factors and underlying mechanisms remain incompletely defined. We sought to characterize clinical, serologic, and bronchoalveolar lavage fluid (BALF) features associated with mucus plugs in RMPP, assess serum–BALF correlations, and identify independent determinants. Methods: From January 2022 to December 2023, children meeting the criteria for RMPP and requiring bronchoscopy were enrolled, and BALF samples were collected for analysis. Patients were stratified according to the presence or absence of mucus plugs. Clinical features, serologic parameters, BALF cytokine profiles, macrolide-resistance mutations, and epithelial and mucin biomarkers were compared between groups. Correlations between systemic inflammatory markers and BALF markers were analyzed, followed by enrichment analyses of differentially expressed BALF markers. Finally, factors independently associated with mucus plug formation were identified. Results: Eighty-eight children with RMPP were enrolled, including 37 with mucus plugs and 51 without. The mucus plug group required more frequent bronchoscopy and exhibited lower lymphocyte, monocyte, platelet, total protein, albumin, sodium, and potassium levels. Conversely, C-reactive protein (CRP), procalcitonin (PCT), creatine kinase (CK), lactate dehydrogenase (LDH), and serum ferritin levels were markedly elevated. BALF analysis revealed significantly higher levels of interleukin (IL)-2, IL-4, IL-6, IL-12p70, IL-17, interferon-γ (IFN-γ), tumor necrosis factor-α (TNF-α), Krebs von den Lungen-6 (KL-6), surfactant protein A (SP-A), and MUC5B in the mucus plug group. Rates of macrolide-resistance mutations were comparable between groups. Serum LDH, CRP, and CK levels correlated positively with BALF pro-inflammatory cytokines (IL-6, IFN-γ, and TNF-α), whereas albumin and sodium levels showed inverse correlations with these cytokines and with epithelial injury markers (KL-6 and SP-A). Enrichment analyses indicated that differentially expressed cytokines and mucins were primarily involved in inflammation-related pathways and immune effector processes. In multivariable analysis, only serum total protein remained independently associated with mucus plug formation. Conclusions: Children with RMPP and mucus plugs exhibited higher BALF cytokine levels, elevated epithelial injury markers (KL-6 and SP-A), and relatively increased MUC5B expression. Lower serum total protein was independently associated with mucus plug formation. These findings refine the pathophysiological understanding of RMPP with mucus plugs and may inform targeted anti-inflammatory and mucus-modulating therapeutic strategies.
- Open Access
- 2 May 2024
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 12 (5) , e0009724
Childhood Mycoplasma pneumoniae : epidemiology and manifestation in Northeast and Inner Mongolia, China
Mycoplasma pneumoniae (MP) is commonly detected in children. However, the epidemiological trends of MP in Northeast (NE) China are unclear. This retrospective study aimed to investigate the prevalence of MP infections in this understudied region. The clinical manifestations and bronchoscopic findings observed in hospitalized patients with severe Mycoplasma pneumoniae pneumonia (SMPP) were collected from comprehensive data obtained from six tertiary hospitals in NE and Inner Mongolian (IM) China, from 1 January 2017 to 31 December 2023. A total of 5,593,530 children who visited the outpatient and emergency departments, and 412,480 inpatient hospitalized children were included in the study. The positivity rate of MP immunoglobulin M (IgM) in the children who visited the outpatient and emergency departments varied from 7.80% to 10.12%, whereas that of MP infection in hospitalized children ranged from 27.18% to 30.10%. Children hospitalized for MP infection were mainly concentrated in the 1- to 4-year (41.39%) and 4- to 7-year (24.25%) age groups. Before 2020, the season with the highest incidence of MP was winter. After the implementation of non-pharmaceutical interventions (NPIs), the MP epidemic season changed, and the number of children with MP infections decreased; however, the proportion of MP infections in hospitalized children did not change significantly. Starting from August 2023, the MP infection rate in outpatient, emergency, and hospitalized children increased sharply, with SMPP and its complications (e.g., plastic bronchitis and pleural effusion) increasing significantly. MP is prevalent in NE and IM, China. When the NPIs ended, MP infection showed a delayed outbreak trend, and the number of children with severe infection increased significantly. IMPORTANCE: In Northeastern (NE) and Inner Mongolia (IM), the incidence of Mycoplasma pneumoniae (MP) infections, including severe Mycoplasma pneumoniae pneumonia (SMPP), is high, posing health risks and imposing substantial economic burdens on the local population. Therefore, it is imperative to prioritize the study of MP prevalence and address the research gaps in MP epidemiology in these areas of China. We obtained a comprehensive collection of pediatric outpatient, emergency, and inpatient data from six public Grade III hospitals. We believe that our study makes a significant contribution to the literature because understanding regional variations in MP infections can help healthcare professionals tailor prevention and treatment strategies, and studying bronchoscopic manifestations can provide insights into the impact of the disease on the respiratory system, potentially leading to a more effective clinical management.
- 2 May 2024
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 12 (5) , e0009724
Open AccessChildhood Mycoplasma pneumoniae : epidemiology and manifestation in Northeast and Inner Mongolia, China
Mycoplasma pneumoniae (MP) is commonly detected in children. However, the epidemiological trends of MP in Northeast (NE) China are unclear. This retrospective study aimed to investigate the prevalence of MP infections in this understudied region. The clinical manifestations and bronchoscopic findings observed in hospitalized patients with severe Mycoplasma pneumoniae pneumonia (SMPP) were collected from comprehensive data obtained from six tertiary hospitals in NE and Inner Mongolian (IM) China, from 1 January 2017 to 31 December 2023. A total of 5,593,530 children who visited the outpatient and emergency departments, and 412,480 inpatient hospitalized children were included in the study. The positivity rate of MP immunoglobulin M (IgM) in the children who visited the outpatient and emergency departments varied from 7.80% to 10.12%, whereas that of MP infection in hospitalized children ranged from 27.18% to 30.10%. Children hospitalized for MP infection were mainly concentrated in the 1- to 4-year (41.39%) and 4- to 7-year (24.25%) age groups. Before 2020, the season with the highest incidence of MP was winter. After the implementation of non-pharmaceutical interventions (NPIs), the MP epidemic season changed, and the number of children with MP infections decreased; however, the proportion of MP infections in hospitalized children did not change significantly. Starting from August 2023, the MP infection rate in outpatient, emergency, and hospitalized children increased sharply, with SMPP and its complications (e.g., plastic bronchitis and pleural effusion) increasing significantly. MP is prevalent in NE and IM, China. When the NPIs ended, MP infection showed a delayed outbreak trend, and the number of children with severe infection increased significantly. IMPORTANCE: In Northeastern (NE) and Inner Mongolia (IM), the incidence of Mycoplasma pneumoniae (MP) infections, including severe Mycoplasma pneumoniae pneumonia (SMPP), is high, posing health risks and imposing substantial economic burdens on the local population. Therefore, it is imperative to prioritize the study of MP prevalence and address the research gaps in MP epidemiology in these areas of China. We obtained a comprehensive collection of pediatric outpatient, emergency, and inpatient data from six public Grade III hospitals. We believe that our study makes a significant contribution to the literature because understanding regional variations in MP infections can help healthcare professionals tailor prevention and treatment strategies, and studying bronchoscopic manifestations can provide insights into the impact of the disease on the respiratory system, potentially leading to a more effective clinical management.
- Open Access
- 31 January 2024
- Published by Wiley
Refractory mycoplasma pneumonia in children: A systematic review and meta-analysis of laboratory features and predictors
Objective:To analyze the clinical characteristics of CRP, LDH, ESR, D-Dimer, Neutrophils (%), Lymphocytes (%) and lung consolidation in refractory Mycoplasma pneumoniae pneumonia (RMPP), and explore their prediction results for RMPP. Methods:Systematic search was conducted in PubMed, Embase, Cochrane Library, Web of Science, CNKI, Wangfang and Cqvip, and the date was set until February 23, 2021. For the continuous variables, Weighted Mean Difference (WMD) with 95% CI or Standard Mean Difference (SMD) with 95% CI was adopted to evaluate CRP, LDH, ESR, D-Dimer, Neutrophils (%), Lymphocytes (%) and the correlation between lung consolidation and RMPP. Results: 20 studies including 5289 patients were included in the analysis, and the results showed: the CRP of the RMPP group [WMD (95%CI): 17.529 (10.514, 24.544), P<0.001], LDH [WMD (95%CI): 114.884 (51.435, 178.333), P<0.001], Neutrophils (%) [WMD (95%CI): 17.271 (0.309, 14.233), P=0.041], Neutrophils (×109/L) [WMD (95%CI): 1.249 (0.307, 2.191), P=0.009] was higher than that of the NRMPP group; the risk of lung consolidation in the RMPP group [OR(95%CI): 14.286 (4.523, 45.120), P<0.001] was higher than that in the NRMPP group; and there was no difference in ESR [WMD (95%CI): 8.111 (-1.339, 17.562), P=0.093], D-Dimer [SMD (95%CI): 0.920 (-0.247, 2.086) p=0.122], Lymphocytes (%) WMD (95%CI): -6.379 (-13.922, 1.163), P=0.097] between the two groups. Conclusions: The available evidence indicates that CRP, LDH, Neutrophils (%), Neutrophils (×109/L) and lung consolidation are risk factors for RMPP.
- 31 January 2024
- Published by Wiley
Open AccessRefractory mycoplasma pneumonia in children: A systematic review and meta-analysis of laboratory features and predictors
Objective:To analyze the clinical characteristics of CRP, LDH, ESR, D-Dimer, Neutrophils (%), Lymphocytes (%) and lung consolidation in refractory Mycoplasma pneumoniae pneumonia (RMPP), and explore their prediction results for RMPP. Methods:Systematic search was conducted in PubMed, Embase, Cochrane Library, Web of Science, CNKI, Wangfang and Cqvip, and the date was set until February 23, 2021. For the continuous variables, Weighted Mean Difference (WMD) with 95% CI or Standard Mean Difference (SMD) with 95% CI was adopted to evaluate CRP, LDH, ESR, D-Dimer, Neutrophils (%), Lymphocytes (%) and the correlation between lung consolidation and RMPP. Results: 20 studies including 5289 patients were included in the analysis, and the results showed: the CRP of the RMPP group [WMD (95%CI): 17.529 (10.514, 24.544), P<0.001], LDH [WMD (95%CI): 114.884 (51.435, 178.333), P<0.001], Neutrophils (%) [WMD (95%CI): 17.271 (0.309, 14.233), P=0.041], Neutrophils (×109/L) [WMD (95%CI): 1.249 (0.307, 2.191), P=0.009] was higher than that of the NRMPP group; the risk of lung consolidation in the RMPP group [OR(95%CI): 14.286 (4.523, 45.120), P<0.001] was higher than that in the NRMPP group; and there was no difference in ESR [WMD (95%CI): 8.111 (-1.339, 17.562), P=0.093], D-Dimer [SMD (95%CI): 0.920 (-0.247, 2.086) p=0.122], Lymphocytes (%) WMD (95%CI): -6.379 (-13.922, 1.163), P=0.097] between the two groups. Conclusions: The available evidence indicates that CRP, LDH, Neutrophils (%), Neutrophils (×109/L) and lung consolidation are risk factors for RMPP.
- Top Cited PapersOpen Access
- 12 January 2023
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 182 (3) , 1239-1249
Clinical features and risk factors of plastic bronchitis caused by refractory Mycoplasma pneumoniae pneumonia in children: a practical nomogram prediction model
Early assessment of refractory Mycoplasma pneumoniae pneumonia (RMPP) with plastic bronchitis (PB) allows timely removal of casts using fiberoptic bronchoscopic manipulation, which relieves airway obstruction and limit sequelae development. This study aimed to analyze clinical data for risk factors and develop a nomogram for early predictive evaluation of RMPP with PB. The clinical data of 1-14 year-old patients with RMPP were retrospectively analyzed. Patients were classified into a PB or non-PB group. The general characteristics, clinical symptoms, laboratory test results, imaging findings, and microscopic changes of the two groups were compared. A statistical analysis of the risk factors for developing PB was performed, and a nomogram model of risk factors was constructed. Of 120 patients with RMPP included, 68 and 52 were in the non-PB and PB groups, respectively. Using multivariate logistic regression analysis, fever before bronchoscopy, extrapulmonary complications, pleural effusion, cough duration, and lactate dehydrogenase (LDH) levels were identified as risk factors. A nomogram was constructed based on the results of the multivariate analysis. The area under the receiver operating characteristic curve value of the nomogram was 0.944 (95% confidence interval: 0.779-0.962). The Hosmer-Lemeshow test displayed good calibration of the nomogram (p = 0.376, R2 = 0.723).Conclusion: The nomogram model constructed in this study based on five risk factors (persistent fever before bronchoscopy, extrapulmonary complications, pleural effusion, cough duration, and LDH levels) prior to bronchoscopy can be used for the early identification of RMPP-induced PB. What is Known:• Refractory Mycoplasma pneumoniae pneumonia (RMPP) in children has been increasingly reported and recognized, which often leads to serious complications.• Plastic bronchitis (PB) is considered to be one of the causes of RMPP, and bronchoscopic treatment should be improved as soon as possible to remove plastic sputum thrombus in bronchus. What is New:• This study determined the risk factors for RMPP-induced PB.• The nomogram model constructed in this study prior to bronchoscopy can be used for the early identification of RMPP-induced PB, which facilitate the early bronchoscopic removal of casts, thereby promoting recovery and reducing cases with poor RMPP prognosis.
- 12 January 2023
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 182 (3) , 1239-1249
Top Cited PapersOpen AccessClinical features and risk factors of plastic bronchitis caused by refractory Mycoplasma pneumoniae pneumonia in children: a practical nomogram prediction model
Early assessment of refractory Mycoplasma pneumoniae pneumonia (RMPP) with plastic bronchitis (PB) allows timely removal of casts using fiberoptic bronchoscopic manipulation, which relieves airway obstruction and limit sequelae development. This study aimed to analyze clinical data for risk factors and develop a nomogram for early predictive evaluation of RMPP with PB. The clinical data of 1-14 year-old patients with RMPP were retrospectively analyzed. Patients were classified into a PB or non-PB group. The general characteristics, clinical symptoms, laboratory test results, imaging findings, and microscopic changes of the two groups were compared. A statistical analysis of the risk factors for developing PB was performed, and a nomogram model of risk factors was constructed. Of 120 patients with RMPP included, 68 and 52 were in the non-PB and PB groups, respectively. Using multivariate logistic regression analysis, fever before bronchoscopy, extrapulmonary complications, pleural effusion, cough duration, and lactate dehydrogenase (LDH) levels were identified as risk factors. A nomogram was constructed based on the results of the multivariate analysis. The area under the receiver operating characteristic curve value of the nomogram was 0.944 (95% confidence interval: 0.779-0.962). The Hosmer-Lemeshow test displayed good calibration of the nomogram (p = 0.376, R2 = 0.723).Conclusion: The nomogram model constructed in this study based on five risk factors (persistent fever before bronchoscopy, extrapulmonary complications, pleural effusion, cough duration, and LDH levels) prior to bronchoscopy can be used for the early identification of RMPP-induced PB. What is Known:• Refractory Mycoplasma pneumoniae pneumonia (RMPP) in children has been increasingly reported and recognized, which often leads to serious complications.• Plastic bronchitis (PB) is considered to be one of the causes of RMPP, and bronchoscopic treatment should be improved as soon as possible to remove plastic sputum thrombus in bronchus. What is New:• This study determined the risk factors for RMPP-induced PB.• The nomogram model constructed in this study prior to bronchoscopy can be used for the early identification of RMPP-induced PB, which facilitate the early bronchoscopic removal of casts, thereby promoting recovery and reducing cases with poor RMPP prognosis.
- Open Access
- 26 June 2022
- Published by Wiley in Journal of Immunology Research
- Vol. 2022, 1-8
Refractory Mycoplasma Pneumonia in Children: A Systematic Review and Meta-analysis of Laboratory Features and Predictors
Background. Mycoplasma pneumoniae is a common pathogen of community-acquired pneumonia (CAP) in children. M. pneumoniae infection is usually regarded as a self-limiting disease, but in some special cases, it can also develop into refractory Mycoplasma pneumoniae pneumonia (RMPP). The aim of this study is to analyze the clinical characteristics of CRP (C-reactive protein), LDH (lactate dehydrogenase), ESR (erythrocyte sedimentation rate), D-dimer, neutrophils (%), lymphocytes (%), and lung consolidation in RMPP and explore their prediction results in the early stage of RMPP, which is important for early treatment. Methods. This systematic search was conducted in PubMed, Embase, Cochrane Library, Web of Science, CNKI, Wangfang, and Cqvip, and the date was set until February 23, 2021. For the continuous variables, mean difference (MD) with 95% CI was adopted to evaluate CRP, LDH, ESR, D-dimer, neutrophils (%), lymphocytes (%), and the correlation between lung consolidation and RMPP. Results. 20 studies including 5289 patients were included in the analysis, and the results showed that the CRP of the RMPP group (MD (95% CI): 22.29 (12.20, 32.38), ), LDH (MD (95% CI): 145.13 (78.62, 211.64), ), neutrophils (%) (MD (95% CI): 7.27 (0.31, 14.23), ), and D-dimer (MD (95% CI): 1.79 (-1.17, 4.74), ) was higher than that of the NRMPP group; the risk of lung consolidation in the RMPP group (OR (95% CI): 14.29 (4.52, 45.12), ) was higher than that in the NRMPP group, and there was no difference in ESR (MD (95% CI): 8.11 (-1.34, 17.56), ) and lymphocytes (%) (MD (95% CI): -6.27 (-12.81, 0.27), ) between the two groups. Conclusion. So, the available evidence indicates that CRP, LDH, neutrophils (%), D-dimer, and lung consolidation are predictive factors for RMPP.
- 26 June 2022
- Published by Wiley in Journal of Immunology Research
- Vol. 2022, 1-8
Open AccessRefractory Mycoplasma Pneumonia in Children: A Systematic Review and Meta-analysis of Laboratory Features and Predictors
Background. Mycoplasma pneumoniae is a common pathogen of community-acquired pneumonia (CAP) in children. M. pneumoniae infection is usually regarded as a self-limiting disease, but in some special cases, it can also develop into refractory Mycoplasma pneumoniae pneumonia (RMPP). The aim of this study is to analyze the clinical characteristics of CRP (C-reactive protein), LDH (lactate dehydrogenase), ESR (erythrocyte sedimentation rate), D-dimer, neutrophils (%), lymphocytes (%), and lung consolidation in RMPP and explore their prediction results in the early stage of RMPP, which is important for early treatment. Methods. This systematic search was conducted in PubMed, Embase, Cochrane Library, Web of Science, CNKI, Wangfang, and Cqvip, and the date was set until February 23, 2021. For the continuous variables, mean difference (MD) with 95% CI was adopted to evaluate CRP, LDH, ESR, D-dimer, neutrophils (%), lymphocytes (%), and the correlation between lung consolidation and RMPP. Results. 20 studies including 5289 patients were included in the analysis, and the results showed that the CRP of the RMPP group (MD (95% CI): 22.29 (12.20, 32.38), ), LDH (MD (95% CI): 145.13 (78.62, 211.64), ), neutrophils (%) (MD (95% CI): 7.27 (0.31, 14.23), ), and D-dimer (MD (95% CI): 1.79 (-1.17, 4.74), ) was higher than that of the NRMPP group; the risk of lung consolidation in the RMPP group (OR (95% CI): 14.29 (4.52, 45.12), ) was higher than that in the NRMPP group, and there was no difference in ESR (MD (95% CI): 8.11 (-1.34, 17.56), ) and lymphocytes (%) (MD (95% CI): -6.27 (-12.81, 0.27), ) between the two groups. Conclusion. So, the available evidence indicates that CRP, LDH, neutrophils (%), D-dimer, and lung consolidation are predictive factors for RMPP.